New Orleans-based technology entrepreneur Nicholas Pashos has been accepted into IndieBio, a four-month biotech accelerator in Silicon Valley that kicks off today (May 1). The program is designed to fast track high-growth biotech startups from across the country.
Through his company BioAestetics, Pashos invented an experimental graft that aims to transform breast reconstruction surgery following cancer treatment.
Pashos is joining a class of seed-invested entrepreneurs. He will receive $250,000 and be living in San Francisco for the duration of the program.
“This is a fantastic opportunity for BioAesthetics,” said Pashos. “It’s more than just the money. The program encompasses quite a lot to get both the business and the science to the next level.”
“The deal includes access to an incredible team of mentors and connections to exceptional resources, exposure and follow on venture-funders,” shared a representative for Tulane, where Pashos is receiving his PhD. “This is an incredible validation of the biotech science coming out of Tulane’s interdisciplinary research programs.”